PASSNCT07741591
Impact of Perioperative Antibiotic Use on Surgical Scarring
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 6 more changesShow less
- Completed without a posted recruiting period
- Final enrollment: 2744 participants (planned 5000)
- Primary completion date changed from estimate of Aug 15, 2026 to Oct 15, 2026
- Study completion date changed from estimate of Aug 15, 2026 to Nov 5, 2026
- Secondary endpoints: details revised at 3 of 4 entries
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Overall Scar Appearance Score Assessed Using a Modified Visual Analogue Scale
Timeframe: Scar photographs were taken during postoperative clinical follow-up, with an overall range from 3 months to 20 years after surgery. Given the wide span, the assessments will be stratified and reported according to the actual time of photography, for exam
Secondary (4)
Scar Color Score Assessed Using a Modified Visual Analogue Scale
Scar Texture Score Assessed Using a Modified Visual Analogue Scale
Scar Width
Scar-Related Complications
Arms and interventions
Retrospective Surgical Scar Cohort
Adult patients who underwent body surface surgery at Nanfang Hospital between January 1, 2005 and January 1, 2025 and have available surgical records, perioperative medication records, and scar outcome information.
Other: Perioperative Antibiotic Exposure
Sites
1 site in 1 country
- Nanfang Hospital, Southern Medical UniversityGuangzhou, Guangdong, China